Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CYP2C19 Polymorphism”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT05264142
What this trial is testing

Risk of CYP2C19 Phenoconversion in Healthy Volunteers With Rapid, Normal, and Intermediate Predicted Metabolizers' Status

Who this might be right for
Healthy
University Hospital, Geneva 45
Not applicableStudy completedNCT01118793
What this trial is testing

Pilot Study on the Effect of High Clopidogrel Maintenance Dosing

Who this might be right for
Coronary Artery Disease
Scripps Health 41
Not applicableUnknownNCT02100761
What this trial is testing

CYP 2C19 Polymorphism and Voriconazole Trough Concentration in Chinese Adult Patients

Who this might be right for
Invasive Pulmonary Aspergillosis
dingshifang 200
Post-approval studies (Phase 4)Study completedNCT02065479
What this trial is testing

A Pharmacodynamic Study Comparing Prasugrel Versus Ticagrelor in Patients Undergoing PCI With CYP2C19 Loss-of-function:

Who this might be right for
Coronary Artery Disease
University of Florida 65
Not applicableUnknownNCT04581967
What this trial is testing

Study of CYP2C19 and ALDH3A1 Polymorphisms in Breast Cancer Patients

Who this might be right for
Breast Cancer Patients
Damanhour University 100
Not applicableStudy completedNCT02191358
What this trial is testing

YouScript IMPACT Registry

Who this might be right for
Adverse Drug EventsAdverse Drug ReactionsDrug Interaction Potentiation+10 more
Genelex Corporation 800
Not applicableActive Not RecruitingNCT06855394
What this trial is testing

Genetic Testing of CYP2C19 in Prognostic Evaluation of Long-Term Major Adverse Cardiac and Vascular Events

Who this might be right for
Atherosclerotic Vascular DiseaseCoronary Arterial Disease (CAD)Atherosclerosis of Coronary Artery+4 more
University of Florida 13,000
Early research (Phase 1)Study completedNCT02299687
What this trial is testing

Influence of CYP2C19 Polymorphism on PK/PD of Omeprazole

Who this might be right for
Stomach Ulcer
Seoul National University Hospital 24
Early research (Phase 1)Study completedNCT00413608
What this trial is testing

Influence of CYP2C19 Genetic Variants on Clopidogrel in Healthy Subjects

Who this might be right for
Healthy
Assistance Publique - Hôpitaux de Paris 140
Not applicableNot Yet RecruitingNCT07439952
What this trial is testing

Biological Collection for the Purpose of Exploring Genetic and Clinical-biological Factors Associated With Variability in Response to Mavacamten in the Treatment of Obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Obstructive Hypertrophic Cardiomyopathy (oHCM)
Assistance Publique - Hôpitaux de Paris 300
Not applicableUnknownNCT04547335
What this trial is testing

The Influence of CYP2C19 Polymorphisms on the Safety and Efficacy of Voriconazole

Who this might be right for
Adverse Drug Reactions
Dokuz Eylul University 34
Post-approval studies (Phase 4)Study completedNCT00354757
What this trial is testing

CYP2C19 Genetic Polymorphism on the Accuracy of Proton-Pump Inhibitor Testing

Who this might be right for
GERD
National Taiwan University Hospital 200
Not applicableStudy completedNCT01094275
What this trial is testing

Role of CYP2C19 Polymorphism in the Drug Interaction Between Clopidogrel and Omeprazole

Who this might be right for
Coronary Artery Disease
Neil Kleiman, MD 75
Early research (Phase 1)UnknownNCT02519400
What this trial is testing

A Genotype Stratification Study for Pharmacokinetics and Pharmacodynamics of Amitriptyline in Healthy Male Subjects

Who this might be right for
Depression
Asan Medical Center 24
Not applicableLooking for participantsNCT06292117
What this trial is testing

Implementation of Onsite Rapid CYP2C19 Assay for Genotype Guided Dual Antiplatelet Therapy After Acute Ischemic Stroke

Who this might be right for
Ischemic StrokeCYP2C19 Polymorphism
University of Virginia 350
Post-approval studies (Phase 4)WithdrawnNCT00299845
What this trial is testing

Randomized Trial for Pharmacogenomics-based Proton Pump Inhibitor Therapy in Children

Who this might be right for
Gastroesophageal Reflux
Osaka University
Not applicableStudy completedNCT04004078
What this trial is testing

An Individualized Administration Research of Voriconazole Based on CYP2C19 Gene Polymorphism and TDM

Who this might be right for
Invasive Fungal Infection
People's Hospital of Zhengzhou University 314
Not applicableStudy completedNCT00806013
What this trial is testing

Study the Effects of CYP2C Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Glipizide

Who this might be right for
Healthy
Chinese Academy of Sciences 36
Large-scale testing (Phase 3)Study completedNCT01641510
What this trial is testing

PRAsugrel or clopIdogrel In Acute Coronary SyndromE With CYP2C19 GENEtic Variants

Who this might be right for
Acute Coronary Syndromes
Dong-A University 70
Testing effectiveness (Phase 2)Looking for participantsNCT05926271
What this trial is testing

POPular GUILTY PILOT: Genotype-guided Clopidogrel Monotherapy

Who this might be right for
Acute Coronary SyndromeCYP2C19 Polymorphism
St. Antonius Hospital 200
Next Page